Context Therapeutics Inc. logo

Context Therapeutics Inc. (CNTX)

Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
0. 62
+0.01
+1.3518%
$
56.36M Market Cap
- P/E Ratio
- Div Yield
1.73M Volume
- Eps
$ 0.61
Previous Close
Add Transaction
Day Range
0.6 0.65
Year Range
0.55 3.62
Want to track CNTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Context Therapeutics Inc. logo
CNTX Context Therapeutics Inc.
13 May 2026
-
-
Context Therapeutics Inc. logo
CNTX Context Therapeutics Inc.
25 Mar 2026
-
-
Context Therapeutics Inc. logo
CNTX Context Therapeutics Inc.
5 Nov 2025
-
-
Context Therapeutics Inc. logo
CNTX Context Therapeutics Inc.
6 Aug 2025
-
-
Context Therapeutics Inc. logo
CNTX Context Therapeutics Inc.
8 May 2025
-
-
Context Therapeutics Inc. logo
CNTX Context Therapeutics Inc.
21 Mar 2025
-
-
Context Therapeutics Inc. logo
CNTX Context Therapeutics Inc.
7 Nov 2024
-
-
Context Therapeutics Inc. logo
CNTX Context Therapeutics Inc.
8 Aug 2024
-
-
Context Therapeutics Inc. logo
CNTX Context Therapeutics Inc.
8 May 2024
-
-
Context Therapeutics Inc. logo
CNTX Context Therapeutics Inc.
20 Mar 2024
-
-
Context Therapeutics Inc. logo
CNTX Context Therapeutics Inc.
9 Nov 2023
-
-

CNTX Earnings Reports FAQ

What is the earnings per share (EPS) for CNTX?

EPS data for CNTX is currently not available, as Context Therapeutics Inc has not reported recent earnings.

What is the company's earnings growth rate?

Context Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Context Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Context Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for CNTX at this time, as Context Therapeutics Inc has no recent EPS data to calculate it.